Massachusetts Financial Services Co. MA Grows Position in Baxter International Inc (BAX)

Massachusetts Financial Services Co. MA increased its holdings in Baxter International Inc (NYSE:BAX) by 790.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,815 shares of the medical instruments supplier’s stock after acquiring an additional 35,343 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Baxter International were worth $3,069,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the stock. Private Trust Co. NA lifted its position in shares of Baxter International by 6.3% during the third quarter. Private Trust Co. NA now owns 11,572 shares of the medical instruments supplier’s stock valued at $892,000 after buying an additional 690 shares during the last quarter. BKD Wealth Advisors LLC lifted its position in shares of Baxter International by 1.8% during the second quarter. BKD Wealth Advisors LLC now owns 41,331 shares of the medical instruments supplier’s stock valued at $3,052,000 after buying an additional 732 shares during the last quarter. FineMark National Bank & Trust lifted its position in shares of Baxter International by 6.0% during the second quarter. FineMark National Bank & Trust now owns 13,239 shares of the medical instruments supplier’s stock valued at $978,000 after buying an additional 753 shares during the last quarter. Cpwm LLC lifted its position in shares of Baxter International by 22.8% during the second quarter. Cpwm LLC now owns 4,230 shares of the medical instruments supplier’s stock valued at $312,000 after buying an additional 784 shares during the last quarter. Finally, Knowledge Leaders Capital LLC lifted its position in shares of Baxter International by 1.0% during the second quarter. Knowledge Leaders Capital LLC now owns 79,384 shares of the medical instruments supplier’s stock valued at $5,862,000 after buying an additional 786 shares during the last quarter. 82.28% of the stock is owned by institutional investors.

In related news, SVP Giuseppe Accogli sold 17,647 shares of the stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $77.27, for a total value of $1,363,583.69. Following the transaction, the senior vice president now owns 59,452 shares in the company, valued at approximately $4,593,856.04. The sale was disclosed in a filing with the SEC, which is available through this link. 0.05% of the stock is currently owned by corporate insiders.

Shares of Baxter International stock opened at $63.87 on Friday. The company has a market capitalization of $33.75 billion, a P/E ratio of 25.75, a P/E/G ratio of 1.71 and a beta of 1.02. The company has a quick ratio of 2.00, a current ratio of 2.60 and a debt-to-equity ratio of 0.38. Baxter International Inc has a 52 week low of $61.05 and a 52 week high of $78.38.

Baxter International (NYSE:BAX) last announced its quarterly earnings data on Wednesday, October 31st. The medical instruments supplier reported $0.80 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.74 by $0.06. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a net margin of 10.90% and a return on equity of 17.67%. Baxter International’s revenue was up 2.2% on a year-over-year basis. During the same period last year, the firm posted $0.64 EPS. Analysts expect that Baxter International Inc will post 3 EPS for the current fiscal year.

BAX has been the subject of several analyst reports. Zacks Investment Research lowered shares of Baxter International from a “buy” rating to a “hold” rating in a research report on Tuesday, July 24th. Royal Bank of Canada reissued a “hold” rating and set a $76.00 price target on shares of Baxter International in a research report on Friday, July 27th. JPMorgan Chase & Co. increased their price target on shares of Baxter International from $80.00 to $85.00 and gave the company an “overweight” rating in a research report on Friday, July 27th. Piper Jaffray Companies increased their price target on shares of Baxter International from $77.00 to $83.00 and gave the company an “overweight” rating in a research report on Friday, July 27th. Finally, Citigroup increased their price target on shares of Baxter International from $74.00 to $76.00 and gave the company a “neutral” rating in a research report on Tuesday, July 31st. Two analysts have rated the stock with a sell rating, four have given a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $75.25.

WARNING: “Massachusetts Financial Services Co. MA Grows Position in Baxter International Inc (BAX)” was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://sportsperspectives.com/2018/11/09/massachusetts-financial-services-co-ma-grows-position-in-baxter-international-inc-bax.html.

About Baxter International

Baxter International Inc provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Recommended Story: What do I need to know about analyst ratings?

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply